Inspirational Teams of Athletes with Diabetes Build Momentum in 2009 with Sponsorship from Long-Acting Insulin Lantus(R) and Rapid-Acting Insulin...(ormation about Team Type 1. Abou...),Health

About Team Type 2

In 2009, with the support of a sponsorship from Lantus(R), Team Type 2, a team of ten amateur cyclists living with type 2 diabetes, was fielded as a new addition to Team Type 1's network of athletes. Team Type 2's long-term goal is to compete in the RAAM, like the Team Type 1 elite team. To help prepare for RAAM, Team Type 2 will participate in several racing events in 2009, primarily the American Diabetes Association's Tour de Cure, a national cycling program designed to raise awareness and funding for diabetes.

Please visit www.TeamType2.org for more information about Team Type 2.

About Diabetes

Diabetes is a chronic, widespread condition in which the body does not produce or properly use insulin -- the hormone needed to transport glucose (sugar) from the blood into the cells of the body for energy. More than 230 million people worldwide are living with the disease, and this number is expected to rise to a staggering 350 million within 20 years. It is estimated that nearly 24 million Americans have diabetes, including an estimated 5.7 million who remain undiagnosed.

About Lantus(R)

Lantus(R) is indicated for the treatment of adults and children (6 years and older) with type 1 diabetes, or adult patients with type 2 diabetes who require basal (long-acting) insulin for the control of hyperglycemia. Lantus(R) is the only 24-hour insulin approved exclusively for use once a day. Insulins have a "peak of action," which refers to the time at which insulin reaches its maximum effect in the body. With Lantus(R), the insulin is released into the bloodstream at a relatively constant rate throughout the day and night; therefore it has no pronounced peak.

About Apidra(R)

Apidra(R) is a rapid-acting insulin that can be a
'/>"/>